Navigation Links
IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP)
Date:7/1/2008

As previously announced, the Company is evaluating the Company's research and development programs, including related assets and costs, and strategic alternatives available to the Company.

For more information about the company and its products, visit http://www.idm-pharma.com.

Forward-Looking Statements

This press release includes forward-looking statements that reflect management's current views of future events including the Company's belief that the data from the L-MTP-PE Phase 3 study warrants regulatory approval in Europe and the United States, the Company's plans to address the remaining questions with respect to the MAA for L-MTP-PE during the clock-stop granted by the CHMP, including the Company's plans for completion of data analysis and submission of responses to the CHMP, the Company's expectation that it will attend an oral explanation hearing at the CHMP's September plenary meeting, the expected timing of receipt of a final opinion from the CHMP and receipt of a final regulatory decision regarding the MAA in the European Union, as well as the Company's plans to collect, analyze and submit additional Phase 3 data in an amended NDA for L-MTP-PE, including the expected timing for such amended NDA, and to respond to other matters raised by the FDA and the Company's plans to evaluate strategic alternatives. Actual results may differ materially from the forward-looking statements due to a number of important factors, including, but not limited to, whether the European Commission will follow the final opinion of the CHMP, whether the timing for the final opinion of the CHMP and the regulatory decision in Europe will occur as expected by the Company, the possibility that additional data from the Phase 3 clinical trial of L-MTP-PE and other information in any amendment to the NDA for L-MTP-PE submitted by the Company may not provide adequate support for regulatory approval of L-MTP-PE
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Isis Pharmaceuticals Conference Call Notice
2. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
3. Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
4. XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
5. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
6. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
7. Pharmasset Receives Notice of Allowance
8. Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis
9. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015  Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a ... be presenting at the Bank of America Merrill Lynch 2015 ... Las Vegas, Nevada on Wednesday, May 13, ... webcast of the presentation can be accessed via Zimmer,s Investor ... archived for replay following the conference. About the ...
(Date:5/6/2015)... , May 6, 2015  The fairness of the ... "Company") by Alexion Pharmaceuticals, Inc. ("Alexion") is being investigated ... law firm, for possible breaches of fiduciary duty and ... of GEVA for agreeing to sell the Company to ... definitive agreement for Alexion to acquire GEVA in a ...
(Date:5/6/2015)... May 6, 2015 China Biologic Products, Inc. ... fully integrated plasma-based biopharmaceutical company in China, today announced ... 2015. First Quarter 2015 Financial Highlights ... of 2015 increased by 25.0% to $70.4 million from ... , Gross profit increased by 18.9% to $45.9 million ...
Breaking Medicine Technology:WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition 2China Biologic Reports Financial Results for the First Quarter of 2015 2China Biologic Reports Financial Results for the First Quarter of 2015 3China Biologic Reports Financial Results for the First Quarter of 2015 4China Biologic Reports Financial Results for the First Quarter of 2015 5China Biologic Reports Financial Results for the First Quarter of 2015 6China Biologic Reports Financial Results for the First Quarter of 2015 7China Biologic Reports Financial Results for the First Quarter of 2015 8China Biologic Reports Financial Results for the First Quarter of 2015 9China Biologic Reports Financial Results for the First Quarter of 2015 10China Biologic Reports Financial Results for the First Quarter of 2015 11China Biologic Reports Financial Results for the First Quarter of 2015 12China Biologic Reports Financial Results for the First Quarter of 2015 13China Biologic Reports Financial Results for the First Quarter of 2015 14China Biologic Reports Financial Results for the First Quarter of 2015 15China Biologic Reports Financial Results for the First Quarter of 2015 16China Biologic Reports Financial Results for the First Quarter of 2015 17China Biologic Reports Financial Results for the First Quarter of 2015 18
... 7, 2011 Henry Schein, Inc., (Nasdaq: ... and services to office-based practitioners, announced today that ... Schein, and Steven Paladino, the Company,s Executive Vice President and ... Global Healthcare Services Conference on February 8, 2011. The conference ...
... Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ... preventive vaccines against cancers and infectious diseases, announced today ... provides the powerful enabling capabilities of electroporation without contacting ... the scientific journal Human Vaccines . While current ...
Cached Medicine Technology:Henry Schein to Present at the UBS 21st Annual Global Healthcare Services Conference 2Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery 2Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery 3Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery 4Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery 5
(Date:5/6/2015)... May 06, 2015 RPS Revolution - a ... the tried and true Rock Paper Scissors game - is ... characters that encourage storytelling and easy to learn rules from ... on an old favorite. RPS Revolution takes the ... whimsical characters that are grouped in set of three called ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 As the exclusive ... special party on the Pirate Ship at Raymond James Stadium ... babies were the first to be drafted into the “Bucs ... and special to spend time with children, particularly those born ... growing up to be Buccaneers fans. I really enjoyed my ...
(Date:5/6/2015)... May 06, 2015 MJNational LLC strengthens ... (OTC: LGBI), Canna Bizcard ™ platform. This exciting new ... Investor Relations, Product Sales / Services. Now you ... national awareness to products, services and ticker symbol through ... system. , MJNational LLC will provide managed support and ...
(Date:5/6/2015)... Edvance360 LMS-SN , a leader ... the Software & Information Industry Association's (SIIA) 30th ... Postsecondary Learning Management Solution" category. Edvance360 LMS-SN won ... for this award seven years running, continued proof that ... the industry. , "The honor of being a ...
(Date:5/6/2015)... 2015 Imprivata ® (NYSE: IMPR), ... David Ting will lead a discussion about the Internet ... and user authentication challenges, during Citrix Synergy ... focus on the benefits of creating a network of ... and patients can share information. It will also emphasize ...
Breaking Medicine News(10 mins):Health News:RPS Revolution Launches Kickstarter Campaign 2Health News:RPS Revolution Launches Kickstarter Campaign 3Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 2Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 3Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 2Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 3Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 2Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 3Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2
... age. But some female birds can slow the ticking ... to results of a study published online last week in ... less fertile as age takes its toll, says biologist Josh ... Carolina, and co-author of the Oikos paper. Older females ...
... TUESDAY, Jan. 18 (HealthDay News) -- Researchers report promising results ... of Alzheimer,s disease, potentially allowing doctors to try to treat ... blood tests could indicate higher risks of dementia later in ... not curable, and existing treatments only have limited effects. ...
... , WEDNESDAY, Jan. 19 (HealthDay News) -- Adults with ... increased risk of developing a common form of degenerative ... study says. "Lewy bodies" -- abnormal clumps of ... brain functioning -- are found in people with Parkinson,s ...
... HealthDay Reporter , TUESDAY, Jan. 18 (HealthDay ... that a controversial treatment for multiple sclerosis can help ... highly skeptical of the claims. The debate ... surgeon from Italy, published an intriguing study that suggested ...
... childhood may lead to premature loss of lung ... adulthood, researchers at Emory University School of Medicine ... severe asthma is important to help stem asthma ... January issue of the Journal of Allergy ...
... Health has been issued a US patent claiming a ... on their surfaces. The method, discovered by John Cambier, ... National Jewish Health, holds promise for treatment of B-cell ... lupus and rejection of organ transplants. This therapeutic approach ...
Cached Medicine News:Health News:Biological clock ticks slower for female birds who choose good mates 2Health News:Progress Reported in Predicting Alzheimer's 2Health News:Adult ADHD Often Precedes Certain Type of Dementia: Study 2Health News:Vein-Opening Treatment for MS Stirs Controversy 2Health News:Vein-Opening Treatment for MS Stirs Controversy 3Health News:Vein-Opening Treatment for MS Stirs Controversy 4Health News:Children with severe asthma experience premature loss of lung function during adolescence 2Health News:Patent awarded for method to dampen immune response 2
Pneumatic High-speed Drill, Throttleless, 90k Rpm, Microaire Connector....
The High Speed Drill handpiece is a well-balanced, high performance drill that provides high speed for,bone sculpting, along with power for difficult osteotomies. Also available in a throttleless mod...
Wire driver, pencil grip, available with various hose connector styles....
Pneumatic micro sagittal saw, 30k cpm, available with various hose connector styles....
Medicine Products: